Behind every clinical trial that successfully reaches the right participants are people quietly making it happen. Thomas (Tom) Hohing is one of those individuals—someone whose work ensures that studies connect with patients in meaningful, human ways….
When Ryan Frazier was only three months old, his family received life-changing news: he had acute myeloid leukemia (AML). Despite multiple rounds of chemotherapy, the cancer came back and spread to his central nervous system. His…
ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that affects nerve cells controlling voluntary muscle movement. Each year, more than 5,000 people in the United States are diagnosed, and around 30,000 people are living…
“I get so excited when I read about new treatments and developments in the fight against ovarian cancer. I would love more than anything to one day see a discovery that will prevent this disease altogether….
When Len Gardner was admitted to the NIH Clinical Center in 1955, he joined a clinical study that would ultimately save his life. Diagnosed with a serious kidney condition, he received an experimental drug—now known as…
Each year, more than 209,000 people in the U.S. are diagnosed with lung cancer, making it one of the most common—and challenging—cancers today. These numbers highlight not only the need for better treatments but also the…
Behind every medical breakthrough is someone who said yes to research. Clinical trials don’t just test new treatments—they open the door to progress in care, diagnosis, and prevention. But for those considering participation, the journey often…